newdrugapprovals.org
NERATINIB, HKI 272, ..Puma presents positive results from phase II trial of its investigational drug PB272
NERATINIB (2E)-N-[4-[[3-chloro-4-[(pyridin-2-yl)methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide [(2E)-N-[4-[[3-chloro-4- [(pyridin-2-yl)methoxy]phenyl]amino]-3-…